A little more than three months since Elevation Pharmaceuticals boasted about the "gold standard" Phase IIb data generated by its nebulized LAMA product for COPD, Sunovion has stepped in to buy the company in a $430 million deal.

THE LIBRARY: WEBINAR

Pharma companies can employ several strategies for obtaining expedited approvals-including, in some cases, acquiring them from other companies. This webinar will feature regulatory experts from the pharma industry who can provide tips on navigating these programs. Register Today!